This report aims to provide a comprehensive presentation of the global market for Hyperimmune Serum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperimmune Serum. This report contains market size and forecasts of Hyperimmune Serum in global, including the following market information:
Global Hyperimmune Serum Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Hyperimmune Serum Market Sales, 2018-2023, 2024-2030, (Kiloton)
Global top five Hyperimmune Serum companies in 2022 (%)
The global Hyperimmune Serum market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hepatitis B Immunoglobulins Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hyperimmune Serum include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hyperimmune Serum manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hyperimmune Serum Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Kiloton)
Global Hyperimmune Serum Market Segment Percentages, by Type, 2022 (%)
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Global Hyperimmune Serum Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Kiloton)
Global Hyperimmune Serum Market Segment Percentages, by Application, 2022 (%)
Government Institutions
Private Sector
Other
Global Hyperimmune Serum Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Kiloton)
Global Hyperimmune Serum Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hyperimmune Serum revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hyperimmune Serum revenues share in global market, 2022 (%)
Key companies Hyperimmune Serum sales in global market, 2018-2023 (Estimated), (Kiloton)
Key companies Hyperimmune Serum sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hyperimmune Serum, market overview.
Chapter 2: Global Hyperimmune Serum market size in revenue and volume.
Chapter 3: Detailed analysis of Hyperimmune Serum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyperimmune Serum in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hyperimmune Serum capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hyperimmune Serum Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hyperimmune Serum Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hyperimmune Serum Overall Market Size
2.1 Global Hyperimmune Serum Market Size: 2022 VS 2030
2.2 Global Hyperimmune Serum Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Hyperimmune Serum Sales: 2018-2030
3 Company Landscape
3.1 Top Hyperimmune Serum Players in Global Market
3.2 Top Global Hyperimmune Serum Companies Ranked by Revenue
3.3 Global Hyperimmune Serum Revenue by Companies
3.4 Global Hyperimmune Serum Sales by Companies
3.5 Global Hyperimmune Serum Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hyperimmune Serum Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hyperimmune Serum Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hyperimmune Serum Players in Global Market
3.8.1 List of Global Tier 1 Hyperimmune Serum Companies
3.8.2 List of Global Tier 2 and Tier 3 Hyperimmune Serum Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hyperimmune Serum Market Size Markets, 2022 & 2030
4.1.2 Hepatitis B Immunoglobulins
4.1.3 Rabies Immunoglobulins
4.1.4 Tetanus Immunoglobulins
4.1.5 Rho(D) Immunoglobulins
4.1.6 Other
4.2 By Type - Global Hyperimmune Serum Revenue & Forecasts
4.2.1 By Type - Global Hyperimmune Serum Revenue, 2018-2023
4.2.2 By Type - Global Hyperimmune Serum Revenue, 2024-2030
4.2.3 By Type - Global Hyperimmune Serum Revenue Market Share, 2018-2030
4.3 By Type - Global Hyperimmune Serum Sales & Forecasts
4.3.1 By Type - Global Hyperimmune Serum Sales, 2018-2023
4.3.2 By Type - Global Hyperimmune Serum Sales, 2024-2030
4.3.3 By Type - Global Hyperimmune Serum Sales Market Share, 2018-2030
4.4 By Type - Global Hyperimmune Serum Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hyperimmune Serum Market Size, 2022 & 2030
5.1.2 Government Institutions
5.1.3 Private Sector
5.1.4 Other
5.2 By Application - Global Hyperimmune Serum Revenue & Forecasts
5.2.1 By Application - Global Hyperimmune Serum Revenue, 2018-2023
5.2.2 By Application - Global Hyperimmune Serum Revenue, 2024-2030
5.2.3 By Application - Global Hyperimmune Serum Revenue Market Share, 2018-2030
5.3 By Application - Global Hyperimmune Serum Sales & Forecasts
5.3.1 By Application - Global Hyperimmune Serum Sales, 2018-2023
5.3.2 By Application - Global Hyperimmune Serum Sales, 2024-2030
5.3.3 By Application - Global Hyperimmune Serum Sales Market Share, 2018-2030
5.4 By Application - Global Hyperimmune Serum Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Hyperimmune Serum Market Size, 2022 & 2030
6.2 By Region - Global Hyperimmune Serum Revenue & Forecasts
6.2.1 By Region - Global Hyperimmune Serum Revenue, 2018-2023
6.2.2 By Region - Global Hyperimmune Serum Revenue, 2024-2030
6.2.3 By Region - Global Hyperimmune Serum Revenue Market Share, 2018-2030
6.3 By Region - Global Hyperimmune Serum Sales & Forecasts
6.3.1 By Region - Global Hyperimmune Serum Sales, 2018-2023
6.3.2 By Region - Global Hyperimmune Serum Sales, 2024-2030
6.3.3 By Region - Global Hyperimmune Serum Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Hyperimmune Serum Revenue, 2018-2030
6.4.2 By Country - North America Hyperimmune Serum Sales, 2018-2030
6.4.3 US Hyperimmune Serum Market Size, 2018-2030
6.4.4 Canada Hyperimmune Serum Market Size, 2018-2030
6.4.5 Mexico Hyperimmune Serum Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Hyperimmune Serum Revenue, 2018-2030
6.5.2 By Country - Europe Hyperimmune Serum Sales, 2018-2030
6.5.3 Germany Hyperimmune Serum Market Size, 2018-2030
6.5.4 France Hyperimmune Serum Market Size, 2018-2030
6.5.5 U.K. Hyperimmune Serum Market Size, 2018-2030
6.5.6 Italy Hyperimmune Serum Market Size, 2018-2030
6.5.7 Russia Hyperimmune Serum Market Size, 2018-2030
6.5.8 Nordic Countries Hyperimmune Serum Market Size, 2018-2030
6.5.9 Benelux Hyperimmune Serum Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Hyperimmune Serum Revenue, 2018-2030
6.6.2 By Region - Asia Hyperimmune Serum Sales, 2018-2030
6.6.3 China Hyperimmune Serum Market Size, 2018-2030
6.6.4 Japan Hyperimmune Serum Market Size, 2018-2030
6.6.5 South Korea Hyperimmune Serum Market Size, 2018-2030
6.6.6 Southeast Asia Hyperimmune Serum Market Size, 2018-2030
6.6.7 India Hyperimmune Serum Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Hyperimmune Serum Revenue, 2018-2030
6.7.2 By Country - South America Hyperimmune Serum Sales, 2018-2030
6.7.3 Brazil Hyperimmune Serum Market Size, 2018-2030
6.7.4 Argentina Hyperimmune Serum Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hyperimmune Serum Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Hyperimmune Serum Sales, 2018-2030
6.8.3 Turkey Hyperimmune Serum Market Size, 2018-2030
6.8.4 Israel Hyperimmune Serum Market Size, 2018-2030
6.8.5 Saudi Arabia Hyperimmune Serum Market Size, 2018-2030
6.8.6 UAE Hyperimmune Serum Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 CSL Behring
7.1.1 CSL Behring Company Summary
7.1.2 CSL Behring Business Overview
7.1.3 CSL Behring Hyperimmune Serum Major Product Offerings
7.1.4 CSL Behring Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.1.5 CSL Behring Key News & Latest Developments
7.2 Grifols
7.2.1 Grifols Company Summary
7.2.2 Grifols Business Overview
7.2.3 Grifols Hyperimmune Serum Major Product Offerings
7.2.4 Grifols Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.2.5 Grifols Key News & Latest Developments
7.3 Biotest
7.3.1 Biotest Company Summary
7.3.2 Biotest Business Overview
7.3.3 Biotest Hyperimmune Serum Major Product Offerings
7.3.4 Biotest Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.3.5 Biotest Key News & Latest Developments
7.4 Kedrion
7.4.1 Kedrion Company Summary
7.4.2 Kedrion Business Overview
7.4.3 Kedrion Hyperimmune Serum Major Product Offerings
7.4.4 Kedrion Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.4.5 Kedrion Key News & Latest Developments
7.5 CBPO
7.5.1 CBPO Company Summary
7.5.2 CBPO Business Overview
7.5.3 CBPO Hyperimmune Serum Major Product Offerings
7.5.4 CBPO Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.5.5 CBPO Key News & Latest Developments
7.6 Emergent (Cangene)
7.6.1 Emergent (Cangene) Company Summary
7.6.2 Emergent (Cangene) Business Overview
7.6.3 Emergent (Cangene) Hyperimmune Serum Major Product Offerings
7.6.4 Emergent (Cangene) Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.6.5 Emergent (Cangene) Key News & Latest Developments
7.7 Kamada
7.7.1 Kamada Company Summary
7.7.2 Kamada Business Overview
7.7.3 Kamada Hyperimmune Serum Major Product Offerings
7.7.4 Kamada Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.7.5 Kamada Key News & Latest Developments
7.8 CNBG
7.8.1 CNBG Company Summary
7.8.2 CNBG Business Overview
7.8.3 CNBG Hyperimmune Serum Major Product Offerings
7.8.4 CNBG Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.8.5 CNBG Key News & Latest Developments
7.9 Hualan Bio
7.9.1 Hualan Bio Company Summary
7.9.2 Hualan Bio Business Overview
7.9.3 Hualan Bio Hyperimmune Serum Major Product Offerings
7.9.4 Hualan Bio Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.9.5 Hualan Bio Key News & Latest Developments
7.10 Shanghai RAAS
7.10.1 Shanghai RAAS Company Summary
7.10.2 Shanghai RAAS Business Overview
7.10.3 Shanghai RAAS Hyperimmune Serum Major Product Offerings
7.10.4 Shanghai RAAS Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.10.5 Shanghai RAAS Key News & Latest Developments
7.11 Sichuan Yuanda Shuyang
7.11.1 Sichuan Yuanda Shuyang Company Summary
7.11.2 Sichuan Yuanda Shuyang Hyperimmune Serum Business Overview
7.11.3 Sichuan Yuanda Shuyang Hyperimmune Serum Major Product Offerings
7.11.4 Sichuan Yuanda Shuyang Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.11.5 Sichuan Yuanda Shuyang Key News & Latest Developments
7.12 ADMA Biologics
7.12.1 ADMA Biologics Company Summary
7.12.2 ADMA Biologics Hyperimmune Serum Business Overview
7.12.3 ADMA Biologics Hyperimmune Serum Major Product Offerings
7.12.4 ADMA Biologics Hyperimmune Serum Sales and Revenue in Global (2018-2023)
7.12.5 ADMA Biologics Key News & Latest Developments
8 Global Hyperimmune Serum Production Capacity, Analysis
8.1 Global Hyperimmune Serum Production Capacity, 2018-2030
8.2 Hyperimmune Serum Production Capacity of Key Manufacturers in Global Market
8.3 Global Hyperimmune Serum Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hyperimmune Serum Supply Chain Analysis
10.1 Hyperimmune Serum Industry Value Chain
10.2 Hyperimmune Serum Upstream Market
10.3 Hyperimmune Serum Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hyperimmune Serum Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hyperimmune Serum in Global Market
Table 2. Top Hyperimmune Serum Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hyperimmune Serum Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hyperimmune Serum Revenue Share by Companies, 2018-2023
Table 5. Global Hyperimmune Serum Sales by Companies, (Kiloton), 2018-2023
Table 6. Global Hyperimmune Serum Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hyperimmune Serum Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Hyperimmune Serum Product Type
Table 9. List of Global Tier 1 Hyperimmune Serum Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hyperimmune Serum Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hyperimmune Serum Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Hyperimmune Serum Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hyperimmune Serum Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Hyperimmune Serum Sales (Kiloton), 2018-2023
Table 15. By Type - Global Hyperimmune Serum Sales (Kiloton), 2024-2030
Table 16. By Application ? Global Hyperimmune Serum Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Hyperimmune Serum Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hyperimmune Serum Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Hyperimmune Serum Sales (Kiloton), 2018-2023
Table 20. By Application - Global Hyperimmune Serum Sales (Kiloton), 2024-2030
Table 21. By Region ? Global Hyperimmune Serum Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Hyperimmune Serum Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hyperimmune Serum Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Hyperimmune Serum Sales (Kiloton), 2018-2023
Table 25. By Region - Global Hyperimmune Serum Sales (Kiloton), 2024-2030
Table 26. By Country - North America Hyperimmune Serum Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hyperimmune Serum Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Hyperimmune Serum Sales, (Kiloton), 2018-2023
Table 29. By Country - North America Hyperimmune Serum Sales, (Kiloton), 2024-2030
Table 30. By Country - Europe Hyperimmune Serum Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hyperimmune Serum Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Hyperimmune Serum Sales, (Kiloton), 2018-2023
Table 33. By Country - Europe Hyperimmune Serum Sales, (Kiloton), 2024-2030
Table 34. By Region - Asia Hyperimmune Serum Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hyperimmune Serum Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Hyperimmune Serum Sales, (Kiloton), 2018-2023
Table 37. By Region - Asia Hyperimmune Serum Sales, (Kiloton), 2024-2030
Table 38. By Country - South America Hyperimmune Serum Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hyperimmune Serum Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Hyperimmune Serum Sales, (Kiloton), 2018-2023
Table 41. By Country - South America Hyperimmune Serum Sales, (Kiloton), 2024-2030
Table 42. By Country - Middle East & Africa Hyperimmune Serum Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hyperimmune Serum Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Hyperimmune Serum Sales, (Kiloton), 2018-2023
Table 45. By Country - Middle East & Africa Hyperimmune Serum Sales, (Kiloton), 2024-2030
Table 46. CSL Behring Company Summary
Table 47. CSL Behring Hyperimmune Serum Product Offerings
Table 48. CSL Behring Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. CSL Behring Key News & Latest Developments
Table 50. Grifols Company Summary
Table 51. Grifols Hyperimmune Serum Product Offerings
Table 52. Grifols Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. Grifols Key News & Latest Developments
Table 54. Biotest Company Summary
Table 55. Biotest Hyperimmune Serum Product Offerings
Table 56. Biotest Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. Biotest Key News & Latest Developments
Table 58. Kedrion Company Summary
Table 59. Kedrion Hyperimmune Serum Product Offerings
Table 60. Kedrion Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Kedrion Key News & Latest Developments
Table 62. CBPO Company Summary
Table 63. CBPO Hyperimmune Serum Product Offerings
Table 64. CBPO Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. CBPO Key News & Latest Developments
Table 66. Emergent (Cangene) Company Summary
Table 67. Emergent (Cangene) Hyperimmune Serum Product Offerings
Table 68. Emergent (Cangene) Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Emergent (Cangene) Key News & Latest Developments
Table 70. Kamada Company Summary
Table 71. Kamada Hyperimmune Serum Product Offerings
Table 72. Kamada Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Kamada Key News & Latest Developments
Table 74. CNBG Company Summary
Table 75. CNBG Hyperimmune Serum Product Offerings
Table 76. CNBG Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. CNBG Key News & Latest Developments
Table 78. Hualan Bio Company Summary
Table 79. Hualan Bio Hyperimmune Serum Product Offerings
Table 80. Hualan Bio Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 81. Hualan Bio Key News & Latest Developments
Table 82. Shanghai RAAS Company Summary
Table 83. Shanghai RAAS Hyperimmune Serum Product Offerings
Table 84. Shanghai RAAS Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. Shanghai RAAS Key News & Latest Developments
Table 86. Sichuan Yuanda Shuyang Company Summary
Table 87. Sichuan Yuanda Shuyang Hyperimmune Serum Product Offerings
Table 88. Sichuan Yuanda Shuyang Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 89. Sichuan Yuanda Shuyang Key News & Latest Developments
Table 90. ADMA Biologics Company Summary
Table 91. ADMA Biologics Hyperimmune Serum Product Offerings
Table 92. ADMA Biologics Hyperimmune Serum Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 93. ADMA Biologics Key News & Latest Developments
Table 94. Hyperimmune Serum Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2021-2023 (Kiloton)
Table 95. Global Hyperimmune Serum Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Hyperimmune Serum Production by Region, 2018-2023 (Kiloton)
Table 97. Global Hyperimmune Serum Production by Region, 2024-2030 (Kiloton)
Table 98. Hyperimmune Serum Market Opportunities & Trends in Global Market
Table 99. Hyperimmune Serum Market Drivers in Global Market
Table 100. Hyperimmune Serum Market Restraints in Global Market
Table 101. Hyperimmune Serum Raw Materials
Table 102. Hyperimmune Serum Raw Materials Suppliers in Global Market
Table 103. Typical Hyperimmune Serum Downstream
Table 104. Hyperimmune Serum Downstream Clients in Global Market
Table 105. Hyperimmune Serum Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hyperimmune Serum Segment by Type in 2022
Figure 2. Hyperimmune Serum Segment by Application in 2022
Figure 3. Global Hyperimmune Serum Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hyperimmune Serum Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Hyperimmune Serum Revenue, 2018-2030 (US$, Mn)
Figure 7. Hyperimmune Serum Sales in Global Market: 2018-2030 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Hyperimmune Serum Revenue in 2022
Figure 9. By Type - Global Hyperimmune Serum Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Hyperimmune Serum Revenue Market Share, 2018-2030
Figure 11. By Type - Global Hyperimmune Serum Sales Market Share, 2018-2030
Figure 12. By Type - Global Hyperimmune Serum Price (US$/Ton), 2018-2030
Figure 13. By Application - Global Hyperimmune Serum Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Hyperimmune Serum Revenue Market Share, 2018-2030
Figure 15. By Application - Global Hyperimmune Serum Sales Market Share, 2018-2030
Figure 16. By Application - Global Hyperimmune Serum Price (US$/Ton), 2018-2030
Figure 17. By Region - Global Hyperimmune Serum Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Hyperimmune Serum Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Hyperimmune Serum Revenue Market Share, 2018-2030
Figure 20. By Region - Global Hyperimmune Serum Sales Market Share, 2018-2030
Figure 21. By Country - North America Hyperimmune Serum Revenue Market Share, 2018-2030
Figure 22. By Country - North America Hyperimmune Serum Sales Market Share, 2018-2030
Figure 23. US Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Hyperimmune Serum Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Hyperimmune Serum Sales Market Share, 2018-2030
Figure 28. Germany Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 29. France Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Hyperimmune Serum Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Hyperimmune Serum Sales Market Share, 2018-2030
Figure 37. China Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 41. India Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Hyperimmune Serum Revenue Market Share, 2018-2030
Figure 43. By Country - South America Hyperimmune Serum Sales Market Share, 2018-2030
Figure 44. Brazil Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Hyperimmune Serum Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Hyperimmune Serum Sales Market Share, 2018-2030
Figure 48. Turkey Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Hyperimmune Serum Revenue, (US$, Mn), 2018-2030
Figure 52. Global Hyperimmune Serum Production Capacity (Kiloton), 2018-2030
Figure 53. The Percentage of Production Hyperimmune Serum by Region, 2022 VS 2030
Figure 54. Hyperimmune Serum Industry Value Chain
Figure 55. Marketing Channels
